{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:42:30Z","timestamp":1760182950664,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.rdc.2017.06.010","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T03:16:54Z","timestamp":1508469414000},"page":"621-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Neurologic Features of Immunoglobulin G4\u2013Related Disease"],"prefix":"10.1016","volume":"43","author":[{"given":"Mahmoud","family":"AbdelRazek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.rdc.2017.06.010_bib1","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A\u00a0new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"issue":"3","key":"10.1016\/j.rdc.2017.06.010_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.rdc.2017.06.010_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"issue":"9976","key":"10.1016\/j.rdc.2017.06.010_bib4","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rdc.2017.06.010_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.12320","article-title":"Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease","volume":"69","author":"Della Torre","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.rdc.2017.06.010_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/all.12342","article-title":"Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy","volume":"69","author":"Mattoo","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.rdc.2017.06.010_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2017.06.010_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2017.06.010_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","article-title":"Lesional CD4+ IFN-gamma+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis","volume":"76","author":"Maehara","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2017.06.010_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2017.06.010_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.rdc.2017.06.010_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.rdc.2017.06.010_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/practneurol-2015-001315","article-title":"Intracranial spread of IgG4-related disease via skull base foramina","volume":"16","author":"Rice","year":"2016","journal-title":"Pract Neurol"},{"issue":"6","key":"10.1016\/j.rdc.2017.06.010_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3171\/2016.4.SPINE1674","article-title":"An orphan disease: IgG4-related spinal pachymeningitis: report of 2 cases","volume":"25","author":"Radotra","year":"2016","journal-title":"J\u00a0Neurosurg Spine"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2017.06.010_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00586-015-4251-0","article-title":"Cervicothoracic spinal cord compression caused by IgG4-related sclerosing pachymeningitis: a case report and literature review","volume":"25","author":"Gu","year":"2016","journal-title":"Eur Spine J"},{"key":"10.1016\/j.rdc.2017.06.010_bib16","first-page":"591.e7-10","article-title":"IgG4-related hypertrophic pachymeningitis at the falx cerebrii with brain parenchymal invasion: a case report","volume":"84(2)","author":"Li","year":"2015","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.rdc.2017.06.010_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/BOR.0b013e3283412f60","article-title":"Autoimmune pancreatitis and IgG4-related sclerosing cholangitis","volume":"23","author":"Takuma","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2017.06.010_bib18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.humpath.2009.04.016","article-title":"Inflammatory pseudotumors of the central nervous system","volume":"40","author":"Lui","year":"2009","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.rdc.2017.06.010_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-related disease and hypertrophic pachymeningitis","volume":"92","author":"Wallace","year":"2013","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.rdc.2017.06.010_bib20","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2017.06.010_bib21","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2017.06.010_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/WNO.0000000000000227","article-title":"Bilateral intracranial optic nerve and chiasmal involvement in IgG4-related disease","volume":"35","author":"Behbehani","year":"2015","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2017.06.010_bib23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jns.2014.10.012","article-title":"Hypertrophic spinal pachymeningitis: idiopathic vs. IgG4-related","volume":"347","author":"Ezzeldin","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"issue":"3","key":"10.1016\/j.rdc.2017.06.010_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1017\/S0317167100017364","article-title":"IgG4-related disease presenting as dural thickening - a rare cause of myelopathy","volume":"41","author":"Zwicker","year":"2014","journal-title":"Can J Neurol Sci"},{"issue":"8","key":"10.1016\/j.rdc.2017.06.010_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00234-012-1012-1","article-title":"Radiological features of IgG4-related disease in the head, neck, and brain","volume":"54","author":"Katsura","year":"2012","journal-title":"Neuroradiology"},{"issue":"11","key":"10.1016\/j.rdc.2017.06.010_bib26","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3174\/ajnr.A3147","article-title":"MR imaging of IgG4-related disease in the head and neck and brain","volume":"33","author":"Toyoda","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.rdc.2017.06.010_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment","volume":"71","author":"Lu","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2017.06.010_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2013.10.008","article-title":"Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis","volume":"266","author":"Della-Torre","year":"2014","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.rdc.2017.06.010_bib29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2017.06.010_bib30","doi-asserted-by":"crossref","first-page":"401890","DOI":"10.1155\/2012\/401890","article-title":"IgG4-related perineural disease","volume":"2012","author":"Inoue","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2017.06.010_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archophthalmol.2011.16","article-title":"Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease","volume":"129","author":"Plaza","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.rdc.2017.06.010_bib32","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3174\/ajnr.A3865","article-title":"Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients","volume":"35","author":"Tiegs-Heiden","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.rdc.2017.06.010_bib33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00330-016-4481-5","article-title":"Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign","volume":"27","author":"Soussan","year":"2016","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.rdc.2017.06.010_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"Bando","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.rdc.2017.06.010_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11102-013-0498-9","article-title":"Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy","volume":"17","author":"Caputo","year":"2014","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/j.rdc.2017.06.010_bib36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.autrev.2008.04.016","article-title":"Pituitary autoimmunity: 30 years later","volume":"7","author":"Caturegli","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.rdc.2017.06.010_bib37","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1210\/jc.2013-1088","article-title":"A\u00a0case of IgG4-related hypophysitis without pituitary insufficiency","volume":"98","author":"Hattori","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.rdc.2017.06.010_bib38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MAJ.0b013e3181fbb6f2","article-title":"A\u00a0case of localized IgG4-related thoracic periarteritis and recurrent nerve palsy","volume":"341","author":"Takahashi","year":"2011","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.rdc.2017.06.010_bib39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jamaneurol.2013.658","article-title":"IgG4-related neuropathy: a case report","volume":"70","author":"Ohyama","year":"2013","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.rdc.2017.06.010_bib40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamaneurol.2014.40","article-title":"Central nervous system manifestation of IgG4-related disease","volume":"71","author":"Regev","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.rdc.2017.06.010_bib41","first-page":"1242","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis involving cerebral parenchyma","volume":"115","author":"Kim","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"7","key":"10.1016\/j.rdc.2017.06.010_bib42","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2017.06.010_bib43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X17300546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X17300546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:16:01Z","timestamp":1760181361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X17300546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0889857X17300546"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2017.06.010","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurologic Features of Immunoglobulin G4\u2013Related Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2017.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}